C&EN logo The Newsmagazine of the Chemical World
Home Current Issue ChemJobs Join ACS
Cover Graphic
June 6, 2005
Vol. 83, Iss. 23

Latest News
Business
Government & Policy
Science/Technology
Careers and Employment
ACS News
   
Back Issues
 
Support
How to log in
Contact Us
Site Map
   
About C&EN
About the Magazine
How to Subscribe
How to Advertise

Latest News RSS Feed

latest news RSS feedWhat is this?

   
Join ACS
Join ACS

  Table of Contents
June 6, 2005
Volume 83, Number 23
p. 1
 
 
  Cover Story  
BIOPHARMACEUTICALS
Biogeneric drug firms position themselves to take advantage of patent expirations for lucrative biologics, but obstacles abound.

COVER: Cambrex photo

   


ADVERTISEMENTVisit Symyx IntelliChem

  Latest News  
  MOLECULAR CONDUITS
Researchers find a new way to control the flow of electrical current through individual molecules.

BIOTECH ANALYSIS
Industry annual report says biotech ventures make up a global network of competing regions and alliances.

PHTHALATE EXPOSURE
Researchers link baby boys' reproductive abnormalities to prenatal exposure to plastics ingredient.

TB MANEUVERS
Structure of DNA-mimicking protein made by M. tuberculosis clarifies mechanism of resistance to fluoroquinolones.

ASBESTOS BILL
Senate legislation would pay asbestos victims from a trust fund in lieu of litigation.

SUBSCRIPTION PRICING
American Chemical Society is altering its policies for subscriptions to its online journals and archives.

FUEL CELLS
Gold catalyst removes undesirable carbon monoxide from gas feed to fuel cells.

NANODELIVERY
Nanotubes composed nearly entirely of DNA might be the ultimate DNA delivery vehicle.

VIAGRA SCRUTINIZED
Federal authorities investigate a possible link between impotence drugs and blindness.

 
 
 

  Business  
  BUSINESS CONCENTRATES

BRAND NEW
Chemical companies seek to define themselves through corporate branding.

ASIAN PETROCHEMICALS
Feedstocks and slowdown in Chinese demand cast cloud over industry conference.

 
 
 

  Government & Policy  
  GOVERNMENT CONCENTRATES

NUCLEAR WASTE
Plans advance for interim storage facility as spent fuel mounts and Yucca Mountain stalls.

 
 
 

  Science & Technology  
  SCIENCE/TECHNOLOGY CONCENTRATES

ANTISMOKING DRUG
Varenicline, a nonnicotine smoking-cessation agent, is now in late-stage Phase III clinical trials.

NEW PRODUCTS
New And Notable In The Chemical Industry.

 
 
 

  Meetings  
 

33RD ACS NORTHEAST REGIONAL MEETING

Call For Papers For Midwest Regional Meeting

 
 
 

  DEPARTMENTS  
  LETTERS

NEWSCRIPTS

 
 
 


ADVERTISEMENT
Visit Teledyne Isco
Advertise Here



COVER STORY
BIOPHARMACEUTICALS

NEWS OF THE WEEK
MOLECULAR CONDUITS

NEWS OF THE WEEK
BIOTECH ANALYSIS

BUSINESS
BRAND NEW

GOVERNMENT & POLICY
NUCLEAR WASTE

SCIENCE & TECHNOLOGY
Protein stabilizes -hemoglobin